Synthesis of transition state analogue inhibitors for purine nucleoside phosphorylase and N-riboside hydrolases

Tetrahedron

Volumn 56, Issue 19, 2000, Pages 3053-3062

  Evans, Gary B ^a   Furneaux, Richard H ^a   Gainsford, Graeme J ^a   Schramm, Vern L ^b   Tyler, Peter C ^a  

^a CALLAGHAN INNOVATION   (New Zealand)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Carbohydrate mimetics; Enzyme inhibitors; Nucleosides; Purines

Indexed keywords

HYDROLASE INHIBITOR; IMMUCILLIN; PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0034607824     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(00)00194-0     Document Type: Article

References (40)

1. Hershfield, M. S.; Mitchell, B. S. The Metabolic Basis of Inherited Disease; 7th ed.; Scriber, C. R., Beaudet, A. L., Sly, W. S., Valle, D. Eds.; McGraw-Hill: New York, 1995, pp 1725-1768 (Chapter 52).
2. Markert L.M. Immunodefic. Rev. 3:1991;45-81.
3. Thelander L., Reichard P. Annu. Rev. Biochem. 48:1979;133-158.
4. Snyder F.F., Jenuth J.P., Mably E.R., Mangat R.K. Proc. Natl. Acad. Sci. USA. 94:1997;2522-2527.
5. Boehncke W-H., Gilbertsen R.B., Hemmer J., Sterry W., Scand. J. Immunol. 39:1994;327-332.
6. Montgomery J.A. Med. Res. Rev. 13:1993;209-228.
7. Sircar J.C., Gilbertsen R.B. Drugs of the Future. 13:1988;653-668.
8. Gopaul D.N., Meyer S., Degano M., Sacchettini J.C., Schramm V.L. Biochemistry. 35:1996;5963-5970.
9. Hammond D.J., Gutteridge W.E. Mol. Biochem. Parasitol. 13:1984;243-261.
10. Dewey V.C., Kidder G.W. Arch. Biochem. Biophys. 157:1973;380-387.
11. Miller R.L., Sabourin C.L.K., Krenitsky T.A., Berens R.L., Marr J.J. J. Biol. Chem. 259:1984;5073-5077.
12. Mazzella L.J., Parkin D.W., Tyler P.C., Furneaux R.H., Schramm V.L. J. Am. Chem. Soc. 118:1996;2111-2112.
13. Parkin D.W., Limberg G., Tyler P.C., Furneaux R.H., Chen X-Y., Schramm V.L. Biochemistry. 36:1997;3528-3534.
14. Parkin D.W., Horenstein B.A., Abdulah D.R., Estupinán B., Schramm V.L. J. Biol. Chem. 266:1991;20658-20665.
15. Estupinán B., Schramm V.L. J. Biol. Chem. 269:1994;23068-23073.
16. Parkin D.W. J. Biol. Chem. 271:1996;21713-21719.
17. Kline P.C., Schramm V.L. Biochemistry. 32:1993;13212-13219.
18. Horenstein B.A., Schramm V.L. Biochemistry. 32:1993;7089-7097.
19. Furneaux R.H., Limberg G., Tyler P.C., Schramm V.L. Tetrahedron. 53:1997;2915-2930.
20. Furneaux R.H., Tyler P.C., Schramm V.L. Bioorg. Med. Chem. 7:1999;2599-2606.
21. Miles R.W., Tyler P.C., Furneaux R.H., Bagdassarian C.K., Schramm V.L. Biochemistry. 37:1998;8615-8621.
22. Miles R.W., Tyler P.C., Evans G.B., Furneaux R.H., Parkin D.W., Schramm V.L. Biochemistry. 38:1999;13147-13154.
23. Li C.M., Tyler P.C., Furneaux R.H., Kicska G., Xu Y., Grubmeyer C., Girven M.E., Schramm V.L. Nature Struct. Biol. 6:1999;582-587.
24. Shi W., Li C.M., Tyler P.C., Furneaux R.H., Grubmeyer C., Schramm V.L., Almo S.C. Nature Struct. Biol. 6:1999;588-593.
25. Shi W., Li C.M., Tyler P.C., Furneaux R.H., Cahill S.M., Girvin M.E., Grubmeyer C., Schramm V.L., Almo S.C. Biochemistry. 38:1999;9872-9880.
26. Horenstein B.A., Zabinski R.F., Schramm V.L. Tetrahedron Lett. 34:1993;7213-7216.
27. Yokoyama M., Akiba T., Ochiai Y., Momotake A., Togo H. J. Org. Chem. 61:1996;6079-6082.
28. Momotake A., Mito J., Yamaguchi K., Togo H., Yokoyama M. J. Org. Chem. 63:1998;7207-7212.
29. Lim M.-I., Klein R.S., Fox J.J. Tetrahedron Lett. 21:1980;1013-1016.
30. Lim M.-I., Klein R.S. Tetrahedron Lett. 22:1981;25-28.
31. Lim M.-I., Ren W.-Y., Otter B.A., Klein R.S. J. Org. Chem. 48:1983;780-788.
32. Girgis N.S., Michael M.A., Smee D.F., Alaghamandan H.A., Robins R.K., Cottam H.B. J. Med. Chem. 33:1990;2750-2755.
33. Pickering L., Malhi B.S., Coe P.L., Walker R.T. Tetrahedron. 51:1995;2719-2728.
34. Kini G.D., Hennen W.J., Robins R.K. J. Org. Chem. 51:1986;4436-4439.
35. Stoeckler J.D. Glazer R.I., Developments in Cancer Chemotherapy. 1984;35-60 CRC Press, Boca Raton, FL.
36. Cremer D., Pople J.A. J. Am. Chem. Soc. 97:1975;1354-1358.
37. 13C resonances assigned to the sugar carbon atoms are ascribed to the presence of restricted rotation about the N-CO bond of the N-Boc group.
38. Hahn, T. Ed.; Reidel: Holland, 1983; Vol. A.
39. Sheldrick G.M. Acta Cryst. A46:1990;467.
40. Sheldrick, G. M. SHELXL-97. Program for the Refinement of Crystal Structures and CIFTAB, Program for Publication of Structures, University of Gottingen, Germany 1997.